Neurologic Features Tied to ARDS in Severe COVID-19 Described
Unclear whether critical illness, medication, infection itself may cause encephalopathy, agitation, confusion
David Shulkin, M.D., on COVID-19 Financial Consequences for Health Care System
Shulkin, ninth secretary for Veterans Affairs, estimates health care provider revenue down about $500 billion
COVID-19 Outcomes Worse With Diabetes, Hyperglycemia
Length of stay longer, mortality higher for those with diabetes and/or acutely uncontrolled hyperglycemia
Infection Rate Up Prior to Detection of Malignant Cancer
Increased odds of influenza, gastroenteritis, hepatitis, pneumonia seen one year before detection
Prevalence of Hypertension in U.S. 45.4 Percent in 2017 to 2018
Prevalence higher among men than women, in non-Hispanic blacks, and increased with age
COVID-19-Linked Changes Reported in Rheumatic Disease Patient Care
Forty-two percent of patients report change in care in previous two weeks
Americans Report Concerns Over Their Mental Health During Pandemic
Counseling experts encourage activities to maintain connections and improve mental health
COVID-19 Pandemic Delays FDA Review of Vaping Products
Federal court has granted FDA request to delay May 12 deadline to Sept. 9
Premature Posting of Remdesivir Findings Were ‘Inconclusive’
Due to low enrollment, study was 'underpowered to enable statistically meaningful conclusions'
FDA Warns About Treating COVID-19 With Unproven Drugs
Chloroquine, hydroxychloroquine may trigger potentially fatal heart rhythm problems in COVID-19 patients
